Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ESLA

Stock Price & Analysis

-
stocks logo
ESLA
-
$
0.000
0.000(0%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

ESLA Stock Price Chart

5D
1M
3M
6M
YTD
1Y
5Y

ESLA Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

ESLA Company Profile

banner

ESLA Technical Analysis

Instant technical analysis with one click on any asset

banner

ESLA Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy ESLA

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

ESLA News Sentiment

AI uncovers potential trading opportunities based on news sentiment

banner

ESLA Technical Analysis

Instant technical analysis with one click on any asset

banner

ESLA Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy ESLA

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

ESLA News Sentiment

AI uncovers potential trading opportunities based on news sentiment

ESLA Fundamental Analysis

Moderate Buy
Buy
Hold
Sell
bubble
High
bubble
Averages
bubble
Low
Analyst
Rating
Action
Price Target
Date
Rating Reason

ESLA News

ESLA FAQs

What is surpport and resistant level for ESLA Stock?

The S1 support level for ESLA Stock is $1.05 ,The R1 resistant level for ESLA Stock is $1.25.

What is the current price of ESLA Stock?

As of the end of day on 2025-02-04, the price of ESLA Stock was $1.1.

What is the market cap of Estrella Immunopharma Inc?

The market cap of ESLA is $39.8M.

What is Estrella Immunopharma Inc (ESLA)'s business?

Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company. The Company is developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Its lead product candidate, EB103, utilizes Eureka's ARTEMIS technology to target CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas. The Company is also developing EB104, which also utilizes Eureka's ARTEMIS technology to target not only CD19, but also CD22, a protein that, like CD19, is expressed on the surface of most B-cell malignancies. The Company is also collaborating with Imugene Limited and its product candidate, CF33-CD19t an oncolytic virus (CF33-CD19t), to research the use of EB103 in conjunction with CF33-CD19t to treat solid tumors.

ESLA Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

ESLA Company Profile

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free